0,774  0,004  Caspase 3 stimulant
0,744  0,005  5 Hydroxytryptamine release stimulant
0,725  0,004  Muscle relaxant
0,711  0,003  Skeletal muscle relaxant
0,718  0,016  Antineoplastic (lung cancer)
0,647  0,006  CYP2C19 inhibitor
0,636  0,006  Cardiodepressant
0,627  0,005  CYP2D6 inhibitor
0,612  0,012  Spasmolytic
0,605  0,007  Antimitotic
0,610  0,015  Antidepressant
0,597  0,008  Antineoplastic (multiple myeloma)
0,610  0,047  Apoptosis agonist
0,582  0,020  Mood disorders treatment
0,579  0,019  Respiratory analeptic
0,596  0,037  Caspase 9 stimulant
0,538  0,006  Tubulin antagonist
0,527  0,004  Alpha 2 adrenoreceptor antagonist
0,524  0,006  Antineoplastic (squamous cell carcinoma)
0,522  0,019  Hepatic disorders treatment
0,517  0,017  Antineoplastic (brain cancer)
0,498  0,010  Sigma receptor agonist
0,484  0,009  P-glycoprotein inhibitor
0,480  0,009  Antineoplastic (carcinoma)
0,500  0,032  Prostate cancer treatment
0,468  0,005  Erectile dysfunction treatment
0,474  0,019  Vasodilator, coronary
0,491  0,037  Antineoplastic (colorectal cancer)
0,473  0,020  Antineoplastic (non-small cell lung cancer)
0,458  0,007  Male reproductive disfunction treatment
0,482  0,035  Histamine release inhibitor
0,500  0,054  Antineoplastic (breast cancer)
0,463  0,017  Antineoplastic (lymphoma)
0,475  0,037  Antineoplastic (colon cancer)
0,443  0,009  Antiparkinsonian, rigidity relieving
0,440  0,008  Alpha adrenoreceptor antagonist
0,431  0,004  Dopamine D1 antagonist
0,454  0,030  Antineoplastic (melanoma)
0,432  0,010  5 Hydroxytryptamine antagonist
0,434  0,023  CYP3A4 inhibitor
0,414  0,025  Antineoplastic (glioblastoma multiforme)
0,395  0,014  Hepatoprotectant
0,418  0,039  Antipsychotic
0,398  0,020  Antineoplastic (small cell lung cancer)
0,402  0,023  Antineoplastic (renal cancer)
0,418  0,040  CYP2D6 substrate
0,399  0,023  Psychostimulant
0,378  0,008  5 Hydroxytryptamine 2A antagonist
0,378  0,009  Dopamine antagonist
0,406  0,037  Analeptic
0,379  0,011  5 Hydroxytryptamine 2 antagonist
0,388  0,020  Sedative
0,439  0,074  Alzheimer's disease treatment
0,368  0,007  Butyrylcholinesterase inhibitor
0,371  0,012  Cholinergic
0,417  0,059  Antileukemic
0,364  0,007  5 Hydroxytryptamine 1 antagonist
0,413  0,058  CYP2C9 substrate
0,389  0,038  Antineoplastic (glioma)
0,358  0,010  Liver fibrosis treatment
0,349  0,007  5 Hydroxytryptamine 1A antagonist
0,345  0,005  LDLR expression enhancer
0,345  0,009  Acetylcholine M1 receptor antagonist
0,334  0,005  Dopamine D3 antagonist
0,337  0,011  Neurotrophic factor enhancer
0,376  0,050  Anxiolytic
0,376  0,050  Antineoplastic (ovarian cancer)
0,335  0,012  Antiparkinsonian, tremor relieving
0,328  0,007  Alpha 2b adrenoreceptor antagonist
0,331  0,010  Acetylcholinesterase inhibitor
0,343  0,025  Anesthetic general
0,375  0,059  Antineoplastic (non-Hodgkin's lymphoma)
0,325  0,009  Dopamine D2 antagonist
0,322  0,009  Topoisomerase I inhibitor
0,358  0,049  Antineoplastic (pancreatic cancer)
0,307  0,009  CDC-like kinase 1 inhibitor
0,344  0,047  Hypoxia-inducible factor 1 alpha inhibitor
0,361  0,069  Vasodilator, peripheral
0,311  0,023  5 Hydroxytryptamine 1E antagonist
0,321  0,034  Cyclic AMP phosphodiesterase inhibitor
0,325  0,042  Antineoplastic (liver cancer)
0,287  0,007  Alpha 2a adrenoreceptor antagonist
0,278  0,008  Phobic disorders treatment
0,312  0,044  Vasodilator
0,274  0,008  Alpha 2c adrenoreceptor antagonist
0,268  0,005  Phosphodiesterase V inhibitor
0,271  0,014  DNA intercalator
0,354  0,097  15-Lipoxygenase inhibitor
0,270  0,014  Carcinogenic, group 1
0,253  0,004  CDC-like kinase 3 inhibitor
0,304  0,056  DNA damaging
0,252  0,004  Antineoplastic alkaloid
0,309  0,064  CYP1A2 substrate
0,279  0,035  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,300  0,057  Antineoplastic (cervical cancer)
0,304  0,065  CYP2C19 substrate
0,236  0,005  Phosphodiesterase 5A inhibitor
0,247  0,015  Alpha 1 adrenoreceptor antagonist
0,255  0,024  Topoisomerase II inhibitor
0,289  0,058  Tumour necrosis factor alpha release inhibitor
0,272  0,041  Abortion inducer
0,241  0,016  Acetylcholine muscarinic antagonist
0,316  0,092  CYP3A4 substrate
0,335  0,116  Antiparkinsonian
0,242  0,023  NADPH oxidase inhibitor
0,253  0,039  Pneumotoxic
0,223  0,012  Breast cancer-resistant protein inhibitor
0,234  0,023  Acetylcholine antagonist
0,216  0,005  Acetylcholine M4 receptor antagonist
0,234  0,024  Cholinergic antagonist
0,225  0,020  Antiadrenergic
0,262  0,058  Tyrosine 3 hydroxylase inhibitor
0,221  0,020  Adrenaline antagonist
0,344  0,143  Antineoplastic (solid tumors)
0,228  0,027  Toxic, respiratory center
0,198  0,005  Phosphodiesterase XI inhibitor
0,198  0,005  Phosphodiesterase 11A inhibitor
0,255  0,063  DNA synthesis inhibitor
0,255  0,065  Antineoplastic (lymphocytic leukemia)
0,258  0,070  NOS2 expression inhibitor
0,202  0,016  Alpha 1a adrenoreceptor antagonist
0,215  0,041  5 Hydroxytryptamine 3E antagonist
0,207  0,033  Uterine stimulant
0,226  0,053  Antimigraine
0,177  0,009  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,183  0,016  Calcium antagonist
0,246  0,078  Antipyretic
0,182  0,015  Histidine decarboxylase inhibitor
0,170  0,008  Alpha 1 adrenoreceptor agonist
0,268  0,110  FMO1 substrate
0,166  0,009  Acetylcholine M2 receptor antagonist
0,171  0,014  5 Hydroxytryptamine uptake inhibitor
0,171  0,018  Alpha 1b adrenoreceptor antagonist
0,170  0,018  Multidrug resistance-associated protein 1 inhibitor
0,275  0,125  Cognition disorders treatment
0,180  0,031  Antitussive
0,151  0,003  Ryanodine receptor antagonist
0,157  0,009  Alpha tubulin antagonist
0,158  0,011  Beta tubulin antagonist
0,155  0,010  5 Hydroxytryptamine 1A agonist
0,177  0,034  Antiviral (Hepatitis B)
0,146  0,003  Factor III inhibitor
0,149  0,006  Dopamine D5 antagonist
0,149  0,015  Dopamine agonist
0,171  0,042  Bipolar disorder treatment
0,163  0,036  5 Hydroxytryptamine 2B antagonist
0,239  0,113  FMO3 substrate
0,130  0,004  Endothelin receptor antagonist
0,203  0,078  Clk dual-specificity kinase inhibitor
0,136  0,012  Dopamine uptake inhibitor
0,172  0,051  CNS active muscle relaxant
0,171  0,052  Activin receptor-like kinase 2 inhibitor
0,124  0,004  Glutamate (mGluR7) antagonist
0,269  0,151  TNF expression inhibitor
0,137  0,019  Alpha adrenoreceptor agonist
0,182  0,066  Tumour necrosis factor antagonist
0,177  0,061  ATPase inhibitor
0,139  0,024  5 Hydroxytryptamine agonist
0,130  0,016  5 Hydroxytryptamine 1 agonist
0,169  0,056  Protein kinase stimulant
0,223  0,112  CYP1A2 inhibitor
0,196  0,087  Antihypertriglyceridemic
0,126  0,019  Glutamate decarboxylase inhibitor
0,213  0,106  Antioxidant
0,134  0,028  Carcinogenic, group 2A
0,159  0,052  Antifungal enhancer
0,119  0,012  Phosphodiesterase VI inhibitor
0,117  0,013  Acetylcholine M5 receptor antagonist
0,165  0,062  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,142  0,042  Microtubule formation inhibitor
0,203  0,103  Antihypercholesterolemic
0,122  0,023  Phosphodiesterase 6D inhibitor
0,122  0,023  Restless leg syndrome treatment
0,117  0,019  Nicotinic alpha4beta2 receptor antagonist
0,102  0,004  Endothelin A receptor antagonist
0,110  0,013  5 Hydroxytryptamine 5A antagonist
0,161  0,064  Heat shock protein 90 antagonist
0,217  0,120  Radiosensitizer
0,108  0,014  5 Hydroxytryptamine 5 antagonist
0,156  0,061  Hemostatic
0,190  0,096  Antineoplastic enhancer
0,209  0,116  Radioprotector
0,253  0,160  CYP2C9 inhibitor
0,136  0,045  MAO A inhibitor
0,112  0,021  Alpha 1d adrenoreceptor antagonist
0,116  0,025  Tocolytic
0,098  0,007  5 Hydroxytryptamine 7 agonist
0,120  0,030  Acetylcholine nicotinic antagonist
0,136  0,046  DNA repair enzyme inhibitor
0,149  0,061  MAO inhibitor
0,178  0,090  Amyloid beta aggregation inhibitor
0,091  0,004  Endothelin B receptor antagonist
0,104  0,018  Acetylcholine M5 receptor agonist
0,193  0,107  Cytostatic
0,112  0,026  ATPase (Vacuolar H+) inhibitor
0,124  0,041  DOPA decarboxylase inhibitor
0,095  0,013  Heat shock protein 90 beta antagonist
0,127  0,045  Sphingosine 1-phosphate receptor 2 agonist
0,144  0,062  Phosphodiesterase inhibitor
0,106  0,025  Dopamine D4 antagonist
0,148  0,067  Attention deficit/hyperactivity disorder treatment
0,085  0,006  Adenylate cyclase 1 inhibitor
0,164  0,088  Antineoplastic (bone cancer)
0,092  0,017  Alpha 2 adrenoreceptor agonist
0,090  0,017  Melanin-concentrating hormone receptor 1 antagonist
0,122  0,049  Activin receptor-like kinase 4 inhibitor
0,189  0,116  RNA-directed DNA polymerase inhibitor
0,156  0,089  UGT2B10 substrate
0,100  0,033  mTOR complex 2 inhibitor
0,127  0,062  Anesthetic local
0,100  0,035  Antiviral (Hepatitis A)
0,089  0,026  Antitreponemal
0,166  0,104  CYP2B6 inhibitor
0,153  0,092  Nitric oxide antagonist
0,087  0,025  MAP kinase 7 inhibitor
0,077  0,018  Dopamine transporter inhibitor
0,115  0,057  Falcipain 3 inhibitor
0,073  0,016  5 Hydroxytryptamine 4 antagonist
0,126  0,069  Papain-like protease (SARS coronavirus) inhibitor
0,085  0,028  Female sexual dysfunction treatment
0,138  0,082  Heat shock protein 70 antagonist
0,085  0,029  5 Hydroxytryptamine 7 antagonist
0,081  0,026  5 Hydroxytryptamine 3 agonist
0,137  0,082  Pregnane X receptor agonist
0,086  0,031  5 Hydroxytryptamine 1B antagonist
0,061  0,007  Phosphodiesterase 6C inhibitor
0,086  0,032  Neuronal nicotinic receptor antagonist
0,080  0,026  Acetylcholine M3 receptor antagonist
0,137  0,084  Genotoxic
0,104  0,053  Nitric-oxide synthase inhibitor
0,065  0,015  Potassium channel small-conductance Ca-activated blocker
0,171  0,122  Free radical scavenger
0,136  0,088  Ca2+-transporting ATPase inhibitor
0,077  0,029  Adrenaline uptake inhibitor
0,142  0,094  Melanin inhibitor
0,116  0,070  Adenylate cyclase inhibitor
0,136  0,091  Chemopreventive
0,051  0,007  Phosphodiesterase 6B inhibitor
0,064  0,022  Nicotinic alpha3beta2 receptor antagonist
0,062  0,020  Dopamine D2 agonist
0,052  0,012  Vesicle monoamine transporter inhibitor
0,104  0,064  Antihypermotility
0,118  0,079  Cyclooxygenase 3 inhibitor
0,076  0,039  Premenstrual syndrome treatment
0,142  0,106  Hearing loss treatment
0,118  0,082  Antiviral (Papilloma)
0,169  0,133  VCAM1 expression inhibitor
0,097  0,063  Sphingomyelinase inhibitor
0,183  0,149  Antineurogenic pain
0,142  0,108  CDC-like kinase 4 inhibitor
0,124  0,090  Lipid peroxidase inhibitor
0,050  0,016  Acid-sensing ion channel blocker
0,042  0,009  Dopamine autoreceptor agonist
0,059  0,028  5 Hydroxytryptamine 1B agonist
0,194  0,163  5 Hydroxytryptamine uptake stimulant
0,232  0,201  Antineoplastic (myeloid leukemia)
0,081  0,052  Topoisomerase II alpha inhibitor
0,062  0,035  Bcl-xL inhibitor
0,057  0,030  5 Hydroxytryptamine 2 agonist
0,061  0,035  5 Hydroxytryptamine 6 antagonist
0,032  0,006  Phosphodiesterase 6G inhibitor
0,032  0,006  Phosphodiesterase 6H inhibitor
0,116  0,090  Toll-Like receptor 9 antagonist
0,077  0,053  Narcotic antagonist
0,078  0,054  Antidote, organophosphates
0,040  0,016  Carnitine palmitoyltransferase 1 inhibitor
0,066  0,043  5 Hydroxytryptamine 1D antagonist
0,076  0,053  Analgesic, opioid
0,039  0,017  Carnitine palmitoyltransferase inhibitor
0,181  0,159  UGT1A9 substrate
0,151  0,130  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,134  0,113  Movement disorders treatment
0,051  0,031  AMPA receptor antagonist
0,043  0,023  Phenylethanolamine N methyltransferase inhibitor
0,187  0,167  Bone diseases treatment
0,092  0,074  Tourette's syndrome treatment
0,028  0,010  Dopamine D1 agonist
0,153  0,136  Aldehyde oxidase inhibitor
0,041  0,025  AMPA 4 receptor antagonist
0,069  0,053  Prokinetic
0,026  0,011  Phosphodiesterase 6A inhibitor
0,090  0,075  Dementia treatment
0,059  0,044  Potassium channel (Ca-activated) blocker
0,159  0,145  VEGF expression inhibitor
0,098  0,084  Interleukin 1b antagonist
0,078  0,065  Inducible nitric-oxide synthase inhibitor
0,087  0,074  Vascular dementia treatment
0,203  0,191  GST M1-1 substrate
0,042  0,030  Guanylate cyclase inhibitor
0,125  0,114  Adenylate cyclase stimulant
0,184  0,173  Gastrin inhibitor
0,021  0,012  Antibiotic Quinolone-like
0,059  0,052  Antiviral (Parainfluenza)
0,122  0,116  UGT2B9 substrate
0,020  0,015  Imidazoline I1 receptor antagonist
0,034  0,028  5 Hydroxytryptamine 3B antagonist
0,073  0,068  5 Hydroxytryptamine 2C antagonist
0,151  0,148  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,044  0,041  Carnitine palmitoyltransferase 1B inhibitor
0,036  0,033  Kainate receptor antagonist
0,135  0,133  Antiarrhythmic
0,081  0,081  Polo-like kinase-1 inhibitor

